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Abstract. The effect of adding a 21-ammosteroid. 
lK:T~REFlAK and a Ca:' antagonist. -lidoflazim:. alone and 
l02ether to UW solution was assessed in a rat liver preser-
vallon model. Following preservatIOn. the livers were 
n.:perl used usmg a closed circull. and the re lease olhepato-
cellularenzvmes( A SAT. A LAT. and LDH) inlOthe perfu-
sale was determined with increasing time. Both drugs re-
duced the amount 01 enzymes lost fr~m the liver. The com-
htnalIOn of the two drulls was better than either drug alone. 
These data suggest th~t both agents may be of ~alue in 
organ preservation for clinical liver transplantation. 
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Introduction 
Lazaroids arc a new group of 21-ammosteroid compounds 
that have recentlv attracted interest because of their 
membrane-stabilizing properties 15. 10. 121. In particular. 
thev have been shown to reduce iron-dependent lipid per· 
OXidation. which is an important mechanism for oxygen 
free. radical induced hepatic injury occurring as a conse-
quence of ischemia and reperfusion. These data suggest 
that these agents may be of value in organ preservation. In 
the present study. the effect 01 adding the lazaroid 
U74500A to University of Wisconsin (UW) solution on 
the hepatlc injury experienced as a result of organ preser-
vallon was evaluated using the isolated. perfused liver. 
The magmtude of the improvement achieved with 
CT~RMMA was compared to that achieved with a Ca 2 ' an-
tagomst.lidotlazine. which is known to reduce the hepatic 
mjurv ltlcurred as a consequence of hepatic preservation 
USltlg the same modell13J.ln addition. the effect of adding 
hoth of these drugs 10 the UW solution was determined. 
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Materials and methods 
:'.la1c LeWIS rate~ (Harlan. fndlanapllil~K Ind.1 yy~Df!!hm!! 2.+0-.-411!! 
wl!re used lor th.: expenment~K l '74'iINlt\ (l ;Ploilll. i\.alamaw(;, 
Mich, I. 21.n me' I. or lidona/me I Kabl Pharmacla. 1..1 Jolla. Caill.!. 
:' m!!'1. or a comhlO;lt1on 01 hoth were I.lIssolved 10 l '\V \olution ( Du· 
Pont Critical Care. Wilmin!!ton. Del.l. No Insulin. methylpredmso. 
lone. or anuhiotlcs were added. The hepat.:clOnl\' and ral-lsolat.:d 
perfusion techmque used were Identical to Ihose prevlOuslv de· 
scnhed 1l.11, Thin\' milliliters olthe preservation medium was' used 
to flush the portal vem. and the livers were stored milK) 011 of the 
same solution. Coni wi livers were Hushed and stored with l IW solu-
\Ion without additives. The livers were stored at O'C lor 72 h helore 
rcperluslOn was started USing a closed cirCUli. with Krehs·Henscleit 
hicarhonate solution COnla1n101! .2 D~" alhumln and .'i mM I!lucose a~ 
the perlusate. :\t .,0 and nO min alter reperluslon. ~amplcs 01 the 
perlusatl! were taken lor analvsls 01 aspartate ammotranslerase 
(ASAT). alanine ammotranslerase (ALATl. and I"etate dehvdrol!e· 
nase (LDH). The amount 01 hepatocellular enzvmes presenl In ihe 
pertusate was dl!termmcd USIO!! a Technlcon RA·:'m analvzer. 
Results were calculated as means ± standard de\l<lllOns (SDI, 
Statis\lcal compansons were pl!rlormed USIOI! the Wilcoxon ran~· 
sum test. t\ " value fc~s Ihen (1,(1:; was wnsldered stallsl\callv ~f!!D 
Ill\lCanl. 
Results 
All livers lost weight during cold storage with no detect-
able difference between groups 11OK~ % ± 2.0 % (Iidona-
zine+lazaroid) vs 10.7% ±3.7°;', (\idot1azine) vs 11.3% 
±4.9% (iazaroid)I. The amount of ASAT. ALAT. and 
LDH released into the perfusate during the perfusion 
period is shown graphicallv in Figs. 1-3. Th(! levels of all 
three enzymes mcrcased with increasmg ttme of the reper-
fusion. The addition of rT~REF{FA to UW solution was as· 
sociated with J stgnificant reductton in the release of 
ASAT and LDH at 3() and flO mm. The reduction in 
ALA T relt:ase was not sij!tlificanl. The addition of both 
Jl!ents to the UW solution rcsulted in a slllnificantlv re-
duced initial release 01 ASAT. ALAT. and -LDH into the 
perfusate medium compared to what was seen with cither 
drug alone. After 00 min 01 rcpertusion. howevcr. the lev-
els of all three enzymes in the perfusate had increased to 
the level achieved with the addition of either agent alonc. 
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e~Kf ,\.11. 111<.: :l1l10UIl! 01 ASAT r<.:I<.:;I\<.:u 11110 th<.: r<K:rlu~al<D: II;" 
"~f1fffC;"lflv r<.:Llu(<.:U ;llIn A .'(j allti II nO mill. \\11<':11 l DT-1~EFEFiyK11-
<1,,1 lall 11<':. lIr hoth urul!~ were auueu to Ihe rn:serv:lIIOlll1leUlum. At 
;11111111 lil<.: Lirul! L'ol11hmatlOn was mort: (tlecllvc Ihan ellher urlll! 
,II"l1e II' c 1I1IIh lor hoth companSOI1SI. whereas Ihere was 110 SII!' 
mllC,1Il1 ullf.:renee al hli mill .• UW \OIUllol1. IIlal.arOlu.llliuo-
Ilalll1e. ~ l<IIarOlu + huof/'Iline .• 1/' =IUlI; .2/' c lUll I: •. i /'-= 
IIHII:-II',IU)25: K~ I' = ().007 
ci~KO .\.11. The al1lllunlOl A LAT releaseti Into the pertusate was not 
'"!l1Illcal1tlvalt<.:reti A aller J() mIO. when L ;i-l~EMFiy ,)r Iluollal.lne 
":IS autieu 10 the rm.:s.:r\,allon meolUm. n Allcr hi} mill a reUUCllUI1 
\\;" \<.:<.:11 III lil<.: IIJolla/lne !!TllUp. hut nOI wllh LJi-l500!\. rhe tiru!.! 
,,,mhlO:lIIOIl was lounu to retiuce Ihe r<.:l!:as<.: 01 enz"me at 30 anu 
f~ 1111111. :\ t .'0 mm Ihe <.:omhlOalion was more 0.:1 h:cu\'<.: Ihan lioulla· 
:111': :111111<': II' -1111311.. UW \oIUII,)n. ~ la/arOlo.IlIiJollal.ln<.:. 
~Oa laI.lnllo .IIJolla/llle .. 1 I' -= lUX)"!: ·2/' -= 11.111: •. ; /' -= IUlio 
Discussiun 
\ major princIpII.: In organ preservallon is the usc of hv-
I'llthernlla. Ilypothermta reduces the rate 01 cellular me-
taholism and therehy the number ot various metabolic 
..:\,ents that occur dunng ischemIa thatlcad to cdl injury 
.lOd death. I {vpothennta is not without SIde effects. how-
t:vcr. that Include cdl swelliOll. This etfect can be counter-
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acted with the usc of a flush solution that contain cell im-
pl.:rml.:ants. such as thosl.: prcsl.:nt In the UW solution 13. 
191. Or!!an preserallon can he improvl.:d further with the 
usc of pharmacological agents that Interfere with key pro-
~esslK:s in the pathogenesis of cell injury occurring as a re-
·mlt of ischemia and reperfusion. Examples 01 such agents 
arc membrane stabilizers including chlorpromazine [17. 
I XI. glucocorticoids [171. oxygen-free radical scavengers 
1151. vasodilators 1111. and calcium antagonists [2.131. 
(/lucocorticoids have heen used extensivelv in ex-
perimental studies to reduce injury experienced with trau-
ma. especially neurotrauma IHI. ischemia 1161 and. in some 
,tudies. the injury associated with llr!!an preservation 17. 
171- The putative ml.:chamsm hehind the protective effects 
lIf !!Iucocortlcolds in these Situations IS helieved to be their 
memhrane stahtlization clfects that limit the development 
;lnd pro!!resslOn 01 iron-dependent lipid peroxidation 
1151. Recl.:ntlv. : l-amtnostcrOids or lazarOlds. a novel 
group ot stl.:rOlds that lack glucocorticoid or mineralocor-
ticoid effects. have heen shown to he potent inhibitors 01 
iron-induced lipid peroxidation III. \toreover_ these 
agents have heen shown to he scavangers of lipid peroxvl 
;lnd and phenoxv radicals 1161. In hoth clinical and ex-
perimental studies. these agents have heen shown to re-
Juce the severity of hrain and spinal cord ischemia 11J.101· 
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ci~KP A. U. ril..: amount 01 LDH reh:aseu into the perfusate was SI!!' 
:lIllcanllv reduceu alter A]O and B til) min. when lj7-l500A. liuo· 
:l.11lnc, lIr h()lh urul!S were auded 10 Ihe rreservallon medium, :\1 
:,1 111 In I he drul! wmhlnallon was more cll.:clIve Ihan LJ7-l'i()OA 
: '''11<.: I I> 111l! h 1. \\hereas there was no sll!ntllcant ult'fcrence In thiS 
"llllnariSOIl at 1111 mm, ,'\1 fl() mm. !tuollazme was assoclateu wHh 
I :c"cr release ()I LDH than L7-l'iOOA alone I P -= 0.(37), • UW 
"HUIl,'Il. ~ la/arOlu. 1iJlidollazmc. ~ lazarolu + liuotlazme, 
i /' ~fgfff: O1D~fffuk:IPm=EFIEuFO: ·-iP=O,IIIt,:.)I'=II.O04: 
" I', 11.llI 1,\ 
In the present study. the effect of adding the 21·aminoste· 
mid U74:'()()A to UW solution on the hepatic injury occur· 
rinl! as a result 01 cold ischemia was assessed using the iso· 
l~tteilK pert used rat liver. The isola tell. perfused liver has 
hL'cn ~hllwn to hc a valuable tool for screening various 
I'rcsernllon techntques. and it has recentlv heen used ex~ 
'.c'IlSI\e I \' hy liS. as well as hv other groups o[ investigators 
~K :~I I-t 17 -191, In some of these studies a sil!nificant 
C\JrrL'latton hetween rerformance In the tsolated. per· 
IlI\eJ liver :1I1L1 tn VIVO assessment 01 liver preservation has 
heen [ounLl [12-141. TIll! Jose of U74500A employed 
f~EF lImol;! or 21.6 ml!jl) was within the dose range found 
Il) he clkctlve in reLluctng ischemic injury to the central 
11I.:rYOLIS system [91, The magnitude olthe cYlOprott!ction 
,1.:hleycJ with U74:,()OA was compared to that achieved 
II Ilh ~f ..:aklum channel hlocker. liLlofiazlOe. This latter 
,1l!Cnt has preViously heen shown to he heneticial in this 
[nOlIeI :It a Jose 01:) mgt! [131. as well as in an orthotopic 
II\er transplant model in the rat [121. L'745(XIA reduced 
the :1I110unt 01 hepatocellular enz\,mes rele:lsed into the 
I'ertusate upon repertuslon atter 72 hoI cold storage. fhe 
! Illoro\cmcnt ohserwd was similarto that ohtaineLl bv ad· 
,1m\! Itdollal.lI1e 10 Ihe L'W solution. 
Ille elicl.:t ul wmhtning a IazarOiLl anJ a calcium I.:han· 
Ilei hlocker \\as also studied. After .'() min ot reperfusion. 
I he enzyme release IOto the perlusate with hoth agents 
,lJJeJ to Ihe L.'W ,;olution was reduced. 'IS compared to 
1 hat "hsCfved when either Jrug was used alone 
," '0 (11110). I'his indicates that the two agents may have 
,In aJJilive <.:Ikct al reductn!,! the cell inlury that occurs 
dunn\.! tSl.:hemJa. (Did storage. and earlv rcpertusion. 
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Since using doses greater than 5 mg of Iidoflazine does 
not n.:sult in a greater reduction in enzyme loss with this 
model [131. the finding of an additional effect with 
1r745(XIA and liLlotlazine together suggests that the two 
~tgents work hv L1ifferent mechantsms to prevent cell in· 
lury. From prior studies with the lal.arolds it appears as If 
the major action 01 such agents is to inhibit lipid peroxi· 
Jation [41. Another mechanism that mav contribute to 
the cell membrane injury experienced during ischemia is 
t he activation of phospholipases that occurs as a result of 
increased cytosolic Ca~D kvcls [ftl. Thus. Gllcium entry 
blockers. like lidonazine. h.lve heen useLl and have been 
shown to reduce the cell injury associated with organ cold 
storage and rcperfusion hy limitin!! the entry of calcium 
into the cytosol. 
In conclUSIOn. in the present study the 21·<tmtnosteroid 
U745(XIA was found to reduce t he liver rnjury expen~ 
enced durin!! (old storage and repertuslon 01 rat liver rn 
IrtrO. The magOltude (II improvement was Similar to that 
(nund wi th a Ca: ~tllla I! 011 lSI. I iJollazlOe, Importantly. the 
effect 01 hoth agents. when lIseJ in wmhlnallon. was 
!!reater than that achieveLl wuh either al!ent alone. at least 
Juring the early (3()·min) reperlusion p~rfEFdK 
kkll()wlt'cigt'/I/(·/If.I', Lluollazlnc was I!cncrouslv gonat~u tw Kahl 
fDharma~lifK La Julia. (';ililorOia. allU l[T-lK~fMf" tlV l·p[ohn. Kalama· 
mo. Michil!an. Thc aUlhors I!ratclullv ad,llowlcdllC Dr. Rcne Du· 
4uesnoy lor IllS !!encral support. I'his ,luJv 1\;1' ,upportcU hy !!rants 
Irom Ihe Dcpartment 01 \'ctcran AILllrs, lit..: SwcJ"h·Amencan 
1'1lunuatlllO. anu hv rrol~if Ilrant I)K2'NI1I lrom tilc i'iallllnal In· 
,tHUle 01 Ilcalth. 
References 
;\nuerson 1)1(. S.lunJcr; RD. IkmcJluk 1', DUl!an LL. Uraul!h· 
kr g~1K Ilalll'D, y1can~ I:D.llorroLk 1..\ Ill/X:') L.lpld hydro· 
I"sls anu rcnlxlJalion 10 mlurcd ,pmal Lord: rarllal rroteetllln 
y~lfh IllClhvlprcullisolllne or \'lIanlin t..: and scIcOlum.l':'IIS Trau· 
Ina 2: ~~T 
~K Ar'Raiah A. ,\hren U. r~nllmark S (1 'I'lt llmprovcJ liver Prl .. "S· 
.:1'\,:1 II on 1m Iransplanlatlon Juc I" .:.t1':lum channel hlockadc. 
Transplant:Ullln :i I: l/n~ 
. , Belzer FO. Southard J H ( 14XXI Princlp[cs 01 sllhu'or!lan prescr· 
\ allon hv 1.'t,lu stma!!c. i'ransplanlallon 4:i: n73 
:84 
.. Brau2hler J M. Pre2enzer JF (1989\ The 21·arnmosterOld inhibl' 
tors of lipid peroxtdation: reactions with lipid peroxvl and phe-
noxy radicals. Free Radic Bioi Med 7: 125 
5. Brau2hler JM. Burton PS. Chase RL. Prel!.enzer JE Jacobsen 
EJ. Van Doomlk Fl. Tustm JM. Aver DE-. Bundy GL (1l}88\ 
~ovel membrane localized iron chclators as Inhibitors ot iron-
Jependent lipid peroxidation. Biochem Pharmacol 37: 3S53-
Wi) 
h. Chien KR. Abrams J. Serroni A. Manln JT. Farber HL (1l}7R\ 
Accelerated phospholipid dCi!radation and associated mem-
hrane dvsfunctlon in Irreversible. ischemic liver cell injury. J Bioi 
Chem 253: .. SOl) 
7. D'AlIesandro A. Southard JH. Kalavol!lu M. Belzer FO (ll}Rti\ 
Effect of drug: pretreatment on liver 'lunclIon following: 2"-hour 
hvpothermlc preservation. Cryobioloi!Y 23: .. 15 
K. Hall ED (11.)85) High dose glucocorticOid treatment improves 
m:urological recovery in headinjured mice. J Neurosurg: 62: SX2 
'I. Hall ED. Pazara KE. Braughler J M ( II.)XX) 21-aminosterOid lipid 
peroxldatlon Inhibitor U7-W()6F protects against cerebral isch-
emia In I!erbils. Stroke Il}: 'N7 
II). Hall ED. Braul!hler JM. McCallJM (11.)l}0\ Roleot oxvg:en radi-
cals In stroke: clfect of the 21-aminosterOlds (lazarOlds). A novel 
class 01 antioxIdants. Prol! Clin Bioi Res 361: .151-362 
II. Hassdl!ren PO. Biber B~ Fornander J Ill}!O\ Improved blood 
Ilnw and protein svnthesls m the postlschemlc liver lollowlng m-
! lISlOn 01 dopamine. J Surl! Res 3 .. : .... 
i 2. J .ll:ohsen cJ. \1cCali J M. Aver DE. \';mDoorntk Fl. Palmer J R. 
Iklonl!" KL. Brau!!hler J\l. Hall ED. Houser OJ. Krook \IA 
I IlNO) i'illvcl21-ammostermds that'lnhlbll Iron-dependent lipid 
peroxldation and protect against central nervous system trauma . 
J Med Chem 33: 11 .. 5-1151 
13. Jacobsson J. Sundberg R. Valdivia LA. Starzl TE (1993) Liver 
preservauon with IidoOazine and the University of WisconSin 
solUllon - a dose-linding study. Transplantation (in press I 
1 .. , Jamieson NY. Sundberg R. Lindell S. Southard JH. Belzer FO 
( Il}XS\ A comparison of cold storage solutions lor hepatic preser-
vation USlnl! the isolated perfused rabbit liver. Crvobiolo2V 25: 300 ' . _. 
15. Olson i~1K Klintmalm GB. Husberl! BS. Nerv JR. Whitten Cw. 
Paulsen AW. McClure T (19R8) Sup'Croxlde dismutase improves 
mg.an prcservallon in liver transplantatton. Transplant Proc 20: 
l)nl 
10. Santiago-Ddpin EA. Figueroa I. Lopez R. VasquezJ (\975) Pro-
tective clfects of steroids in liver Ischemia. Am SUflz41: nX3 
17, Sundberl! ~K Lindell S. Jamieson NV. Southard JH. Belzer FO 
(Il}XX\ Effects of chlorpromazine and methylprednisolone on 
perfusiun preservation of rabbulivers. Cryobiology 25: .. 17 
I X. Sundberg ~K Ar"Rajab A. Ahrcn B. Ben2mark S (1989) Chlor-
promazl~e pretreatment of the donor 1m-proves liver preserva-
lion quality wllh UW solullon In an expertmental model. Trans-
plantallon 4X: 7 .. 2-744 
11.). Sundherg R. A(Rajab A Ahren B. Bengmark S (1991 \ The 
functional effects of suppressIon 01 hvpothermla-induced cell 
,wellIng In liver presl.:rv<lllon bv ,old ~tllrageK Cryobiolo!!y O~: 
1:'i0 
20. Young W. Wojak J C. DI.:Crl.:SCll1l 'Ii ( IlJXX \ 21-amtnosterold rc-
ducl.:s lOll shifts allu eucm;1 III the rat mldule cerebral arterv 
model 01 regIOnal ischemia. Stroke 21): IOU 
